The article text was unavailable because access was denied, so the reported development cannot be independently summarised from the material provided. Based on the headline alone, the Trump administration is said to be ending a Medicare premium subsidy programme, which could matter for beneficiaries if it raises their out-of-pocket prescription drug costs.

The URL indicates the policy concerns Medicare Part D subsidies and that they are due to expire in 2027. No further details, including the number of people affected, the subsidy’s value or the administration’s rationale, were available in the supplied text.